BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹53 Cr | ₹63 Cr | ₹35 Cr | ₹8.22 Cr | ₹2.59 Cr |
What is the latest Total Current Liabilities ratio of BALAXI PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹53 Cr |
Mar2022 | ₹63 Cr |
Mar2021 | ₹35 Cr |
Mar2020 | ₹8.22 Cr |
Mar2019 | ₹2.59 Cr |
How is Total Current Liabilities of BALAXI PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹53 Cr | -16.02 | |
Mar2022 | ₹63 Cr | 82.37 | |
Mar2021 | ₹35 Cr | 321.95 | |
Mar2020 | ₹8.22 Cr | 217.82 | |
Mar2019 | ₹2.59 Cr | - |
Compare Total Current Liabilities of peers of BALAXI PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BALAXI PHARMACEUTICALS | ₹655.5 Cr | -2.6% | 3.2% | 13.4% | Stock Analytics | |
ADANI ENTERPRISES | ₹323,236.0 Cr | -7.2% | -12.4% | 56.4% | Stock Analytics | |
REDINGTON | ₹16,319.5 Cr | -4.5% | -6% | 21.6% | Stock Analytics | |
HONASA CONSUMER | ₹13,864.7 Cr | -0.9% | 4% | NA | Stock Analytics | |
MMTC | ₹10,578.0 Cr | -4.8% | -8.3% | 152.6% | Stock Analytics | |
MSTC | ₹5,798.9 Cr | -8.6% | -11.8% | 194.4% | Stock Analytics |
BALAXI PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BALAXI PHARMACEUTICALS | -2.6% |
3.2% |
13.4% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses